Kim et al., 1999 - Google Patents
Subcellular localization of hepatitis C viral proteins in mammalian cellsKim et al., 1999
- Document ID
- 17821703558955784550
- Author
- Kim J
- Song W
- Chung K
- Back S
- Jang S
- Publication year
- Publication venue
- Archives of virology
External Links
Snippet
We determined the subcellular localization of hepatitis C viral (HCV) proteins as a first step towards the understanding of the functions of these proteins in the mammalian cell (CHO- K1). We used fluorescence emitted from green fluorescent protein (GFP)-fused to the viral …
- 230000004960 subcellular localization 0 title abstract description 35
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense
- C12N2770/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense ssRNA Viruses positive-sense
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay for hepatitis non-A, non-B hepatitis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kim et al. | Subcellular localization of hepatitis C viral proteins in mammalian cells | |
You et al. | Hepatitis C virus core protein interacts with cellular putative RNA helicase | |
Satoh et al. | Cleavage of hepatitis C virus nonstructural protein 5A by a caspase-like protease (s) in mammalian cells | |
Mottola et al. | Hepatitis C virus nonstructural proteins are localized in a modified endoplasmic reticulum of cells expressing viral subgenomic replicons | |
Otsuka et al. | Hepatitis C virus core protein inhibits apoptosis via enhanced Bcl-xL expression | |
Chung et al. | Nonstructural protein 5A of hepatitis C virus inhibits the function of karyopherin β3 | |
Majumder et al. | Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice | |
Goh et al. | The hepatitis C virus core protein interacts with NS5A and activates its caspase-mediated proteolytic cleavage | |
Satoh et al. | The N-terminal region of hepatitis C virus nonstructural protein 3 (NS3) is essential for stable complex formation with NS4A | |
Kato | Molecular virology of hepatitis C virus | |
Sabile et al. | Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates | |
Otsuka et al. | Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability | |
Ishido et al. | Complex formation of NS5B with NS3 and NS4A proteins of hepatitis C virus | |
Suzuki et al. | Processing and functions of Hepatitis C virus proteins | |
Hong et al. | Enzymatic characterization of hepatitis C virus NS3/4A complexes expressed in mammalian cells by using the herpes simplex virus amplicon system | |
Irshad et al. | Hepatitis C virus core protein: an update on its molecular biology, cellular functions and clinical implications | |
Suzuki et al. | Ubiquitin-mediated degradation of hepatitis C virus core protein is regulated by processing at its carboxyl terminus | |
Moradpour et al. | Characterization of three novel monoclonal antibodies against hepatitis C virus core protein | |
KR100394693B1 (en) | Hepatitis G virus and its molecular cloning method | |
Mondelli et al. | Significance of the immune response to a major, conformational B-cell epitope on the hepatitis C virus NS3 region defined by a human monoclonal antibody | |
Tong et al. | Physical interaction between hepatitis C virus NS4B protein and CREB-RP/ATF6β | |
Lu et al. | Phosphorylation of hepatitis C virus core protein by protein kinase A and protein kinase C | |
Yagi et al. | Identification of novel HCV subgenome replicating persistently in chronic active hepatitis C patients | |
Watashi et al. | Cytoplasmic localization is important for transcription factor nuclear factor-κB activation by hepatitis C virus core protein through its amino terminal region | |
Kato et al. | Processing of hepatitis C virus core protein is regulated by its C‐terminal sequence |